Alvotech

Alvotechverified

ALVO

Price:

$11.99

Market Cap:

$3.61B

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to t...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2022-06-16

Stock Exchange

NASDAQ

Ticker

ALVO

The Enterprise Value as of November 2024 (TTM) for Alvotech (ALVO) is 4.68B

According to Alvotech’s latest financial reports and current stock price. The company's current Enterprise Value is 4.68B. This represents a change of 34.33% compared to the average of 3.48B of the last 4 quarters.

Alvotech (ALVO) Historical Enterprise Value (quarterly & annually)

How has ALVO Enterprise Value performed in the past?

The mean historical Enterprise Value of Alvotech over the last ten years is 1.65B. The current 4.68B Enterprise Value has changed 28.28% with respect to the historical average. Over the past ten years (40 quarters), ALVO's Enterprise Value was at its highest in in the June 2024 quarter at 4.37B. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

1.65B

Median

994.84M

Minimum

0

Maximum

3.67B

Alvotech (ALVO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Alvotech Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual Enterprise Value = 3.67B

Minimum Annual Increase = -14.04%

Minimum Annual Enterprise Value = 0

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20233.67B35.25%
20222.72B217.58%
2021855.18M-14.04%
2020994.84MInfinity%

Alvotech (ALVO) Average Enterprise Value

How has ALVO Enterprise Value performed in the past?

The current Enterprise Value of Alvotech (ALVO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

2.41B

5-year avg

1.65B

10-year avg

1.65B

Alvotech (ALVO) Enterprise Value vs. Peers

How is ALVO’s Enterprise Value compared to its peers?

Alvotech’s Enterprise Value is less than Intra-Cellular Therapies, Inc. (0), less than Catalent, Inc. (8.64B), less than Amphastar Pharmaceuticals, Inc. (15.68B), greater than Assertio Holdings, Inc. (2.62B), greater than ANI Pharmaceuticals, Inc. (91.56M), greater than Alkermes plc (1.68B), greater than Dr. Reddy's Laboratories Limited (4.63B), less than Collegium Pharmaceutical, Inc. (1.04T), greater than Pacira BioSciences, Inc. (1.80B), greater than Cyclo Therapeutics, Inc. (1.21B), greater than Athenex, Inc. (20.10M), greater than MedMen Enterprises Inc. (9.07M), greater than Lifecore Biomedical, Inc. (385.18M), greater than Lucy Scientific Discovery Inc. (400.55M), greater than null (2.06M),

Build a custom stock screener for Alvotech (ALVO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alvotech using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alvotech (ALVO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alvotech or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Alvotech's Enterprise Value?

What is the highest Enterprise Value for Alvotech (ALVO)?

What is the 3-year average Enterprise Value for Alvotech (ALVO)?

What is the 5-year average Enterprise Value for Alvotech (ALVO)?

How does the current Enterprise Value for Alvotech (ALVO) compare to its historical average?